CRSP CRISPR Therapeutics AG

CRISPR Therapeutics AG is a gene editing company. It is engaged in the development of CRISPR/Cas9-based therapeutics.

$125.68  -1.60 (-1.26%)
As of 02/26/2021 15:59:54 EST     IEX book   CBOE book


Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Mid cap
Health Care
Biotechnology
Switzerland
Switzerland
10/19/2016
75,428,927
2,327,647
$9,600,593,829
0.00%
SEC Edgar Online
10-Q
10-K
H17182108
CH0334081137
BDHF4K6

Valuation   (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
-27.50
5.65
0.00
-20.96%
-48,520.86%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy